Imax Analyst Price Targets - Benzinga

Imax Corp

IMAXNYSE

Trade with Public

Trade with Public

$54.80

-1.53-2.72%

Ult. Agg.: Sep 30, 5:17 PM

$54.58

-1.75-3.1%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Imax Analyst Price Targets - Benzinga

Imax Analyst Price Targets

Wall Street analyst price targets and consensus rating for Imax (IMAX).

Price Target Range — 9 Quarters

Analyst Consensus — 12 Analysts

11Buy

1Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$51Upside to Avg. PT-6.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 24, 2026	Morgan Stanley	Daniel Duran	Initiate	Overweight	$63
Sep 9, 2026	Rosenblatt	Steve Frankel	PT Raise	Buy	$60→$65
Sep 4, 2026	Goldman Sachs	Mike Burton	PT Raise	Neutral	$42→$50
Sep 3, 2026	Roth Capital	Eric Handler	PT Raise	Buy	$50→$60
Sep 2, 2026	Macquarie	Chad Beynon	PT Raise	Outperform	$50→$55
Aug 24, 2026	B. Riley Securities	Drew Crum	PT Raise	Buy	$52→$61
Aug 19, 2026	Rosenblatt	Steve Frankel	Maintained	Buy	$60
Aug 10, 2026	Rosenblatt	Steve Frankel	PT Raise	Buy	$50→$60
Jul 24, 2026	Barrington Research	Patrick Sholl	PT Raise	Outperform	$46→$50
Jul 24, 2026	JP Morgan	David Karnovsky	PT Raise	Overweight	$47→$50
Jul 24, 2026	Roth Capital	Eric Handler	PT Raise	Buy	$48→$50
Jul 24, 2026	B. Riley Securities	Drew Crum	PT Raise	Buy	$48→$52
Jul 24, 2026	Wells Fargo	Omar Mejias	PT Raise	Equal-Weight	$41→$45
Jul 24, 2026	Wedbush	Alicia Reese	PT Raise	Outperform	$46→$54
Jul 24, 2026	Rosenblatt	Steve Frankel	PT Raise	Buy	$47→$50
Jul 20, 2026	Rosenblatt	Steve Frankel	Maintained	Buy	$47
Jul 16, 2026	Wells Fargo	Omar Mejias	Downgrade	Overweight→Equal-Weight	$47→$41
Jul 8, 2026	Macquarie	Chad Beynon	PT Raise	Outperform	$46→$48
May 22, 2026	Benchmark	Mike Hickey	PT Raise	Buy	$44→$60
May 1, 2026	Macquarie	Chad Beynon	Maintained	Outperform	$46

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Morgan Stanley Initiates Coverage On Imax with Overweight Rating, Announces Price Target of $63

Morgan Stanley analyst Daniel Duran initiates coverage on Imax (NYSE:IMAX) with a Overweight rating and announces Price Target of $63.

Benzinga Newsdesk

Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.

Avi Kapoor

PRO
Rosenblatt Maintains Buy on Imax, Raises Price Target to $65

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $60 to $65.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Imax, Raises Price Target to $50

Goldman Sachs analyst Mike Burton maintains Imax (NYSE:IMAX) with a Neutral and raises the price target from $42 to $50.

Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on Imax, Raises Price Target to $60

Roth Capital analyst Eric Handler maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $50 to $60.

Benzinga Newsdesk

PRO
Macquarie Maintains Outperform on Imax, Raises Price Target to $55

Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $50 to $55.

Benzinga Newsdesk